Critical Medicines Act EU seals deal on Critical Medicines Act after marathon talks After 12 hours of overnight negotiations, EU lawmakers reached a provisional agreement on the Critical Medicines Act aimed at boosting Europe’s pharmaceutical resilience
Inside EU Health Inside EU Health: Support for health NGOs; Europe’s East-West healthcare divide; Hungarian health minister European Patients’ Forum welcomes MEP support to restore funding for health NGO’s; Europe’s East-West healthcare divide; From viral victory dance to cabinet role, Hegedűs named as new Hungarian health minister
Inside EU Health Inside EU Health: Tariff chaos, court setback on Urban Wastewater for pharma; EMA starts its search for a new Executive Director ‘Tariff chaos’ but pharmaceuticals may stay outside the fray; industry groups continue to fight Wastewater Treatment Directive despite court setback; EMA starts its search for a new Executive Director
Urban Wastewater Treatment Directive Industry groups continue to fight Wastewater Treatment Directive despite court setback EFPIA has lost their legal battle, but hope that national cases will address their concerns
Inside EU Health Inside EU Health: EFPIA compares 10 biopharma strategies; EU cancer strategy scrutinised; agencies reassure on infant formula EFPIA publishes a comparative analysis of the strategies of 10 countries; ECA casts doubt on EU cancer strategy’s targets and funding; agencies says infant formula is a low risk following recall
Inside EU Health Inside EU Health: EFPIA raises its CMA concerns; Élysée dismisses Trump 'Fake News'; EU funds €147 million for health research and investment in Africa EFPIA raises its CMA concerns; Élysée dismisses Trump’s Davos claim on medicine prices as 'Fake News'; EU funds €147 million for health research and investment in Africa
Inside EU Health Inside EU Health: Council position on Critical Medicines Act; UK-US deal will removes tariffs; will the GLP-1 manufacturers step up to WHO challenge Council reaches position on Critical Medicines Act; UK-US deal will increase the cost of drugs but removes tariffs; will the GLP-1 manufacturers step up to WHO challenge
Inside EU Health Inside EU Health: Pharma trilogue advances; reinforcing EU preparedness; EFPIA concerns on HTA process Pharma trilogue talks advance; reinforcing EU preparedness; and EFPIA raises concerns on HTA process
Inside EU Health Inside EU Health: Pharma and biotech lead in public research patents; and, EFPIA cautiously optimistic on clinical trials reform Pharma and biotech lead in public research patents; and, EFPIA cautiously optimistic on clinical trials reform
Life Sciences EU research ministers support ‘European Life Sciences Investment Fund’ EU research ministers push for bolder action to secure Europe’s life sciences future
